Skip to main content

We've saved some files called cookies on your device. These cookies are:

  • essential for the site to work
  • to help improve our website by collecting and reporting information on how you use it

We would also like to save some cookies to help tailor communications.

BETA
You're viewing an updated version of this service - your feedback will help us to improve it.

Contract Notice

PROGRAMME OF RESEARCH ON WORK-RELATED STRESS (WRS)

  • First published: 09 February 2024
  • Last modified: 09 February 2024
  • Version: N/A
  • This file may not be fully accessible.

  •  

Information icon

The buyer is not using this website to administer the notice.

To record your interest or obtain additional information or documents please find instructions within the Full Notice Text. (NOTE: Contract Award Notices and Prior Information Notices do not normally require a response)

Information icon
You are viewing an expired notice.

Contents

Summary

OCID:
ocds-h6vhtk-04383b
Published by:
HEALTH & SAFETY EXECUTIVE
Authority ID:
AA80731
Publication date:
09 February 2024
Deadline date:
11 March 2024
Notice type:
Contract Notice
Has documents:
No
Has SPD:
No
Has Carbon Reduction Plan:
N/A

Abstract

Reducing work-related ill health (with a specific focus on mental health and stress) is a key strategic objective in HSE's strategy from 2022-2032 Protecting people and places: HSE strategy 2022 to 2032 Implementing this strategic objective is dependent on having urgent access to underpinning evidence to enable the shaping of standards required in HSE's guidance which enables proposed inspection and enforcement activity. An improved evidence base will allow HSE to advise others is relation to WRS.

Three critical research questions/topics have been identifed that are required to help provide this evidence:

RQ1 What primary and secondary control measures/interventions show efficacy for preventing and mitigating WRS?

RQ2 How is WRS assigned and/or labelled by (a) an organisation and (b) medical professionals?

RQ3 What are the enablers and barriers to organisations effectively controlling WRS risk?

Further information can be found within the ITT documentation at https://in-tendhost.co.uk/hse

Full notice text

Contract notice

Section I: Contracting authority

I.1) Name and addresses

Health & Safety Executive

Redgrave Court, Merton Road

Bootle, Liverpool

L20 7HS

UK

E-mail: tenders@hse.gov.uk

NUTS: UKD73

Internet address(es)

Main address: www.hse.gov.uk

I.3) Communication

The procurement documents are available for unrestricted and full direct access, free of charge at:

https://in-tendhost.co.uk/hse/aspx/Home


Additional information can be obtained from the abovementioned address


Tenders or requests to participate must be sent electronically to:

https://in-tendhost.co.uk/hse/aspx/Home


I.4) Type of the contracting authority

Body governed by public law

I.5) Main activity

General public services

Section II: Object

II.1) Scope of the procurement

II.1.1) Title

PROGRAMME OF RESEARCH ON WORK-RELATED STRESS (WRS)

Reference number: HSE/T4555

II.1.2) Main CPV code

73000000

 

II.1.3) Type of contract

Services

II.1.4) Short description

The Health and Safety Executive (HSE) is a Crown non-departmental public body with specific statutory functions in relation to health and safety. It is appointed by the Secretary of State for Work and Pensions. HSE regulates a wide range of industries including offshore, chemical, agriculture and construction industries as well as a range of manufacturing industries, and employs around 2700 staff including policy advisers, inspectors, technologists and scientific and medical advisers. HSE's job is to prevent people being killed, injured or made ill by work in Great Britain.

HSE consists of a governing Board comprising of a Chair, the Chief Executive of HSE and ten non-executive members, all of whom are appointed by the Secretary of State for Work and Pensions after consultation with organisations representing employers, employees, local authorities and others, as appropriate.

HSE comprises various directorates and groups and is led by a senior management board. HSE works from over 30 locations throughout Great Britain.

Reducing work-related ill health (with a specific focus on mental health and stress) is a key strategic objective in HSE's strategy from 2022-2032 Protecting people and places: HSE strategy 2022 to 2032 Implementing this strategic objective is dependent on having urgent access to underpinning evidence to enable the shaping of standards required in HSE's guidance which enables proposed inspection and enforcement activity. An improved evidence base will allow HSE to advise others is relation to WRS.

Three critical research questions/topics have been identifed that are required to help provide this evidence:

RQ1 What primary and secondary control measures/interventions show efficacy for preventing and mitigating WRS?

RQ2 How is WRS assigned and/or labelled by (a) an organisation and (b) medical professionals?

RQ3 What are the enablers and barriers to organisations effectively controlling WRS risk?

Further information can be found within the ITT documentation at https://in-tendhost.co.uk/hse

II.1.5) Estimated total value

Value excluding VAT: 400 000.00  GBP

II.1.6) Information about lots

This contract is divided into lots: No

II.2) Description

II.2.3) Place of performance

NUTS code:

UK

II.2.4) Description of the procurement

Reducing work-related ill health (with a specific focus on mental health and stress) is a key strategic objective in HSE's strategy from 2022-2032 Protecting people and places: HSE strategy 2022 to 2032 Implementing this strategic objective is dependent on having urgent access to underpinning evidence to enable the shaping of standards required in HSE's guidance which enables proposed inspection and enforcement activity. An improved evidence base will allow HSE to advise others is relation to WRS.

Three critical research questions/topics have been identifed that are required to help provide this evidence:

RQ1 What primary and secondary control measures/interventions show efficacy for preventing and mitigating WRS?

RQ2 How is WRS assigned and/or labelled by (a) an organisation and (b) medical professionals?

RQ3 What are the enablers and barriers to organisations effectively controlling WRS risk?

Further information can be found within the ITT documentation at https://in-tendhost.co.uk/hse

II.2.5) Award criteria

Price is not the only award criterion and all criteria are stated only in the procurement documents

II.2.6) Estimated value

Value excluding VAT: 400 000.00  GBP

II.2.7) Duration of the contract, framework agreement or dynamic purchasing system

Duration in months: 2

This contract is subject to renewal: No

II.2.9) Information about the limits on the number of candidates to be invited

II.2.10) Information about variants

Variants will be accepted: Yes

II.2.11) Information about options

Options: No

II.2.13) Information about European Union funds

The procurement is related to a project and/or programme financed by European Union funds: No

Section IV: Procedure

IV.1) Description

IV.1.1) Type of procedure

Open procedure

IV.1.8) Information about Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No

IV.2) Administrative information

IV.2.2) Time limit for receipt of tenders or requests to participate

Date: 11/03/2024

Local time: 12:00

IV.2.4) Languages in which tenders or requests to participate may be submitted

EN

IV.2.7) Conditions for opening of tenders

Date: 12/03/2024

Local time: 09:00

Section VI: Complementary information

VI.1) Information about recurrence

This is a recurrent procurement: No

VI.4) Procedures for review

VI.4.1) Review body

Tommy Johnson - HSE Head of Procurement

Redgrave Court, Merton Road

Bootle, Liverpool

L20 7HS

UK

E-mail: tenders@hse.gov.uk

VI.5) Date of dispatch of this notice

08/02/2024

Coding

Commodity categories

ID Title Parent category
73000000 Research and development services and related consultancy services Research and Development

Delivery locations

ID Description
100 UK - All

Alert region restrictions

The buyer has restricted the alert for this notice to suppliers based in the following regions.

ID Description
There are no alert restrictions for this notice.

About the buyer

Main contact:
tenders@hse.gov.uk
Admin contact:
N/a
Technical contact:
N/a
Other contact:
N/a

Further information

Date Details
No further information has been uploaded.

0800 222 9004

Lines are open 8:30am to 5pm Monday to Friday.

Rydym yn croesawu galwadau'n Gymraeg.

We welcome calls in Welsh.